NuGene Growing Its Stem-Cell Cosmeceuticals Biz; Regulatory Risks Noted
This article was originally published in The Rose Sheet
Executive Summary
NuGene's sales have soared with expanded distribution, but increased regulation continues to be a risk to its human stem-cell-based cosmeceuticals business, the firm notes. Skin and hair-care line extensions will launch later this year, and the company is considering developing an in-house sales force.